PTPRC and non-small cell lung carcinoma: We also identified that ∼10% of all CD45+ immune cells found in NSCLC specimens displayed a cellular phenotype of CD45+CD14−CD68−CD66b−CD33+, labelled here as CD14−CD33+ for short (Fig. 2b and Supplementary Fig. 12).